# Extracorporeal Photopheresis in Sezary Syndrome

> **NCT05157581** · — · RECRUITING · sponsor: **Oleg E. Akilov, MD, PhD** · enrollment: 20 (estimated)

## Conditions studied

- Sezary Syndrome

## Interventions

- **DEVICE:** Extracorporeal photopheresis (ECP)
- **DRUG:** Methoxsalen Injection

## Key facts

- **NCT ID:** NCT05157581
- **Lead sponsor:** Oleg E. Akilov, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-04
- **Primary completion:** 2028-12
- **Final completion:** 2028-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-12-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05157581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05157581, "Extracorporeal Photopheresis in Sezary Syndrome". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05157581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*